{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:06:52Z","timestamp":1785787612300,"version":"3.56.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2S","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Mozambique introduced 10-valent-pneumococcal conjugate vaccine (PCV10) in 2013. We aimed to evaluate the indirect effect of PCV10 on invasive pneumococcal disease (IPD) and clinical severe pneumonia (CSP) in infants aged less than 10 weeks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Routine surveillance data for IPD and CSP among admitted infants less than 10 weeks of age were analyzed to compare IPD and CSP incidence using demographic surveillance data from pre- and post-PCV10 periods. IPD was defined as isolation of pneumococcus from blood or cerebrospinal fluid, and CSP according to World Health Organization criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The incidence of IPD and CSP among infants less than 10 weeks decreased by 87% [incidence rate ratio (IRR): 0.13; 95% confidence interval (CI): 0.02\u20130.95] from 283\/100,000 in the pre-PCV to 36\/100,000 children year at risk (CYAR) post-PCV, and by 62% (IRR: 0.38; 95% CI: 0.27\u20130.52) from 4100\/100,000 pre-PCV to 1550\/100,000 CYAR post-PCV periods, respectively. Vaccine-type IPD incidence declined by 92% (IRR: 0.18; 95% CI: 0.02\u20131.34) from 205\/100,000 pre-PCV to 36\/100,000 CYAR post-PCV, though the reduction was not statistically significant. The mortality rate due to IPD among infants less than 10 weeks declined from 47\/100,000 CYAR in the pre-PCV to 0 in the post-PCV period. Mortality due to CSP declined by 29% (IRR: 0.71; 95% CI: 0.34\u20131.50), from 457\/100,000 CYAR in the pre-PCV to 324\/100,000 in the post-PCV periods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>PCV10 introduction led to substantial declines in the incidence of IPD, CSP and associated mortality in infants too young to be vaccinated (less than 10 weeks) in Mozambique, suggesting indirect protection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000004638","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T12:01:37Z","timestamp":1739534497000},"page":"S75-S79","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Effect of the Ten-valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease and Pneumonia in Infants Younger Than Ten Weeks of Age in Southern Mozambique: A Population-based Prospective Surveillance Study"],"prefix":"10.1097","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1201-1009","authenticated-orcid":false,"given":"S\u00e9rgio","family":"Massora","sequence":"first","affiliation":[{"name":"Centro de Investiga\u00e7\u00e3o em Sa\u00fade de Manhi\u00e7a (CISM), Maputo, Mo\u00e7ambique"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9lio","family":"Mucavele","sequence":"additional","affiliation":[{"name":"Centro de Investiga\u00e7\u00e3o em Sa\u00fade de Manhi\u00e7a (CISM), Maputo, Mo\u00e7ambique"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria da Gloria","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Division of Bacterial Diseases, Respiratory Diseases Branch, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e1cio","family":"Mandomando","sequence":"additional","affiliation":[{"name":"Centro de Investiga\u00e7\u00e3o em Sa\u00fade de Manhi\u00e7a (CISM), Maputo, Mo\u00e7ambique"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Cha\u00faque","sequence":"additional","affiliation":[{"name":"Centro de Investiga\u00e7\u00e3o em Sa\u00fade de Manhi\u00e7a (CISM), Maputo, Mo\u00e7ambique"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benild","family":"Moiane","sequence":"additional","affiliation":[{"name":"Centro de Investiga\u00e7\u00e3o em Sa\u00fade de Manhi\u00e7a (CISM), Maputo, Mo\u00e7ambique"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Tembe","sequence":"additional","affiliation":[{"name":"Centro de Investiga\u00e7\u00e3o em Sa\u00fade de Manhi\u00e7a (CISM), Maputo, Mo\u00e7ambique"},{"name":"Instituto Nacional de Sa\u00fade, Minist\u00e9rio de Sa\u00fade, Maputo, Mozambique"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad B.","family":"Omer","sequence":"additional","affiliation":[{"name":"Peter O\u00b4Donnell Jr School of Public Health, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quique","family":"Bassat","sequence":"additional","affiliation":[{"name":"Centro de Investiga\u00e7\u00e3o em Sa\u00fade de Manhi\u00e7a (CISM), Maputo, Mo\u00e7ambique"},{"name":"ISGlobal, Hospital Cl\u00ednic \u2013 Universitat de Barcelona, Barcelona, Spain"},{"name":"ICREA, Barcelona, Spain"},{"name":"Pediatrics Department, Hospital Sant Joan de D\u00e9u, Universitat de Barcelona, Barcelona, Spain"},{"name":"Consorcio de Investigaci\u00f3n Biom\u00e9dica en Red de Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Verani","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Division of Bacterial Diseases, Respiratory Diseases Branch, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Men\u00e9ndez","sequence":"additional","affiliation":[{"name":"Centro de Investiga\u00e7\u00e3o em Sa\u00fade de Manhi\u00e7a (CISM), Maputo, Mo\u00e7ambique"},{"name":"ISGlobal, Hospital Cl\u00ednic \u2013 Universitat de Barcelona, Barcelona, Spain"},{"name":"Consorcio de Investigaci\u00f3n Biom\u00e9dica en Red de Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloren\u00e7","family":"Quint\u00f3","sequence":"additional","affiliation":[{"name":"Centro de Investiga\u00e7\u00e3o em Sa\u00fade de Manhi\u00e7a (CISM), Maputo, Mo\u00e7ambique"},{"name":"ISGlobal, Hospital Cl\u00ednic \u2013 Universitat de Barcelona, Barcelona, Spain"},{"name":"Consorcio de Investigaci\u00f3n Biom\u00e9dica en Red de Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betuel","family":"Siga\u00faque","sequence":"additional","affiliation":[{"name":"Centro de Investiga\u00e7\u00e3o em Sa\u00fade de Manhi\u00e7a (CISM), Maputo, Mo\u00e7ambique"},{"name":"John Snow Inc. (JSI) on the Maternal and Child Survival Program\u2013MCSP (USAID Grantee), Maputo, Mozambique."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azucena","family":"Bardaj\u00ed","sequence":"additional","affiliation":[{"name":"Centro de Investiga\u00e7\u00e3o em Sa\u00fade de Manhi\u00e7a (CISM), Maputo, Mo\u00e7ambique"},{"name":"ISGlobal, Hospital Cl\u00ednic \u2013 Universitat de Barcelona, Barcelona, Spain"},{"name":"Consorcio de Investigaci\u00f3n Biom\u00e9dica en Red de Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"key":"R1-20260413","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1016\/S2214-109X(18)30247-X","article-title":"Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000\u201315.","volume":"6","author":"Wahl","year":"2018","journal-title":"Lancet Global Health"},{"key":"R2-20260413","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(20)30880-X","article-title":"Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in the Gambia: 10 years of population-based surveillance.","volume":"21","author":"Mackenzie","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"R3-20260413","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.00309-10","article-title":"Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States.","volume":"2","author":"Simonsen","year":"2011","journal-title":"MBio"},{"key":"R4-20260413","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/INF.0000000000000210","article-title":"Bacterial meningitis in Malawian infants <2 months of age: etiology and susceptibility to World Health Organization first-line antibiotics.","volume":"33","author":"Swann","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R5-20260413","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1097\/00006454-199910001-00007","article-title":"Etiology of serious infections in young Gambian infants.","volume":"18","author":"Mulholland","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"R6-20260413","first-page":"154","article-title":"Aetiology of community-acquired neonatal sepsis in low- and middle-income countries.","volume":"1","author":"Waters","year":"2011","journal-title":"J Glob Health"},{"key":"R7-20260413","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/INF.0b013e3181a78185","article-title":"Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings.","volume":"28","author":"Cheung","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R8-20260413","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance.","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"R9-20260413","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jama.295.14.1668","article-title":"Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine.","volume":"295","author":"Poehling","year":"2006","journal-title":"JAMA"},{"key":"R10-20260413","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/cid\/cis934","article-title":"Impact of the 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in infants younger than 90 days in England and Wales.","volume":"56","author":"Ladhani","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R11-20260413","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/INF.0b013e318187a87d","article-title":"Community-acquired bacteremia among children admitted to a rural hospital in Mozambique.","volume":"28","author":"Siga\u00faque","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R12-20260413","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0190687","article-title":"Burden of invasive pneumococcal disease among children in rural Mozambique: 2001\u20132012.","volume":"13","author":"Sigauque","year":"2018","journal-title":"PLoS One"},{"key":"R16-20260413","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/ije\/dyaa218","article-title":"Cohort profile update: Manhi\u00e7a health and demographic surveillance system (HDSS) of the Manhi\u00e7a Health Research Centre (CISM).","volume":"50","author":"Nhacolo","year":"2021","journal-title":"Int J Epidemiol"},{"issue":"2 Febuary","key":"R18-20260413","doi-asserted-by":"crossref","first-page":"e0245461","DOI":"10.1371\/journal.pone.0245461","article-title":"Quantifying the gender gap in the HIV care cascade in southern Mozambique: we are missing the men.","volume":"16","author":"Lopez-Varela","year":"2021","journal-title":"PLoS One"},{"issue":"January 1997","key":"R19-20260413","first-page":"1","article-title":"A 10 year study of the cause of death in children under 15 years in Manhi\u00e7a, Mozambique.","volume":"9","author":"Sacarlal","year":"2009","journal-title":"BMC Public Health"},{"key":"R20-20260413","first-page":"353","article-title":"Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies.","volume":"83","author":"Cherian","year":"2004","journal-title":"Bull World Heal Organ"},{"key":"R21-20260413","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1128\/JCM.02498-06","article-title":"Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA.","volume":"45","author":"Carvalho","year":"2007","journal-title":"J Clin Microbiol"},{"key":"R22-20260413","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1128\/JCM.02927-12","article-title":"Sequential triplex real-time PCR assay for detecting 21 pneumococcal capsular serotypes that account for a high global disease burden.","volume":"51","author":"Pimenta","year":"2013","journal-title":"J Clin Microbiol"},{"key":"R23-20260413","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/S0140-6736(18)33005-8","article-title":"Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study.","volume":"393","author":"Hammitt","year":"2019","journal-title":"Lancet"},{"key":"R24-20260413","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/INF.0000000000003606","article-title":"Changing incidence of invasive pneumococcal disease in infants less than 90 days of age before and after introduction of the 13-valent pneumococcal conjugate vaccine in Blantyre, Malawi.","volume":"41","author":"Koenraads","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"R25-20260413","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/jpids\/piaa132","article-title":"Effect of 10-valent pneumococcal conjugate vaccine on Streptococcus pneumoniae nasopharyngeal carriage among children less than 5 years old: 3 years post-10-valent pneumococcal conjugate vaccine introduction in Mozambique.","volume":"10","author":"Valenciano","year":"2021","journal-title":"J. Pediatric Infect. Dis. Soc"},{"key":"R26-20260413","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S1473-3099(17)30321-3","article-title":"Impact of the introduction of pneumococcal conjugate vaccination on pneumonia in The Gambia: population-based surveillance and case-control studies.","volume":"17","author":"Mackenzie","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"R27-20260413","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1056\/NEJMoa1209165","article-title":"U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination.","volume":"369","author":"Griffin","year":"2013","journal-title":"N Engl J Med"},{"key":"R28-20260413","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/cid\/ciu524","article-title":"Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality.","volume":"59","author":"Harboe","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R29-20260413","doi-asserted-by":"crossref","first-page":"e1003537","DOI":"10.1371\/journal.pmed.1003537","article-title":"Estimated impact of the pneumococcal conjugate vaccine on pneumonia mortality in South Africa, 1999 through 2016: an ecological modelling study.","volume":"18","author":"Kleynhans","year":"2021","journal-title":"PLoS Med"},{"key":"R30-20260413","year":"2021"},{"key":"R31-20260413","doi-asserted-by":"crossref","first-page":"e17765","DOI":"10.1371\/journal.pone.0017765","article-title":"Ten years of surveillance for invasive Streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in Malawi.","volume":"6","author":"Everett","year":"2011","journal-title":"PLoS One"},{"key":"R32-20260413","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/QAD.0b013e328341b7f1","article-title":"The impact of antiretroviral treatment on the burden of invasive pneumococcal disease in South African children: a time series analysis.","volume":"25","author":"Nunes","year":"2011","journal-title":"AIDS"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000004638","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:12:06Z","timestamp":1785784326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000004638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":28,"journal-issue":{"issue":"2S","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004638","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}